Loading...
UK Trademark — IPO
MAVUPHARMA
Application UK00918020179 · Registered
Quick Facts
| Application Number | UK00918020179 |
| Status | Registered |
| Owner | Mavupharma, Inc. |
| Filed | 2019-02-07 |
| Registered | 2019-06-22 |
| Renewal Due | 2029-02-07 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
Yes. MAVUPHARMA is currently a registered UK trademark, with renewal due on 2029-02-07. It is protected under UK intellectual property law and can be enforced against infringing uses.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 5 — Pharmaceuticals
Pharmaceutical preparations; pharmaceutical preparations for the prevention and treatment of cancer and infectious diseases.
Class 42 — Scientific & IT Services
pharmaceutical research and development; consulting services in the fields of pharmaceutical research and development; conducting scientific research and clinical trials relating to pharmaceuticals for the prevention and treatment of cancer and infectious diseases; research and development of pharmaceuticals for the prevention and treatment of cancer and infectious diseases; information, consultancy and advisory services relating to all of the aforesaid.
Timeline
- Filed: 2019-02-07
- Registered: 2019-06-22
- Renewal due: 2029-02-07
About This Trademark
'MAVUPHARMA' is a registered trademark on the UK IPO register, owned by Mavupharma, Inc.. The application (UK00918020179) was filed on 7 February 2019 and registered on 22 June 2019. The registration is set to expire on 7 February 2029.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services).
The trademark is represented by Abion UK Limited.
Frequently Asked Questions
Who owns UK trademark UK00918020179 ('MAVUPHARMA')?
UK trademark UK00918020179 for the mark 'MAVUPHARMA' in Class 5, 42 is recorded on the UK IPO register as owned by Mavupharma, Inc.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00918020179 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00918020179 for the mark 'MAVUPHARMA' as registered.
Which Nice classes is UK trademark UK00918020179 registered under?
UK trademark UK00918020179 for the mark 'MAVUPHARMA' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services). The filed specification reads: Class 5: Pharmaceutical preparations; pharmaceutical preparations for the prevention and treatment of cancer and infectious diseases. | Class 42: pharmaceutical research and development; consulting services in the fields of pharmaceutical research and development; conducting scientific research and clinical trials r…
When was UK trademark UK00918020179 filed?
UK trademark UK00918020179 for the mark 'MAVUPHARMA' was filed at the UK IPO on 7 February 2019 and registered on 22 June 2019.
When does UK trademark UK00918020179 need to be renewed?
UK trademark UK00918020179 for the mark 'MAVUPHARMA' is currently recorded as valid until 7 February 2029, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00918020179?
Abion UK Limited is listed as the attorney / representative of record for UK trademark UK00918020179 for the mark 'MAVUPHARMA' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Cross-Register Filings
Trademarks matching "MAVUPHARMA" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
US — United States (USPTO)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| MAVUPHARMASame applicant | 88143556 | 606 | 2018-10-04 |
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
United States (USPTO)
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.